Company news
Rhythm Biosciences Limited (ASX:RHY) news
Rhythm Biosciences Limited news releases on 6ix. Latest, Feb 20, 2019: RHY Signs first ColoSTAT site for Clinical Trial - Study 7
Press releases — page 4
RHY Signs first ColoSTAT site for Clinical Trial - Study 7
February 19, 2019
Corporate Presentation
February 10, 2019
Rhythm Completes Reagent Development Program
December 4, 2018
Appointment of CEO - Senior Management Changes
November 27, 2018
AGM Presentation
November 25, 2018
Final Antibody Selection Complete
October 2, 2018
Rhythm completes cloning of key reagent ahead of schedule
June 20, 2018
Rhythm Granted Biomarker Patent in Europe
May 16, 2018
RHYs Four Antibodies Pass all Three Key Screening Tests
May 14, 2018
Reagent Development Update
April 23, 2018
Appendix 4D - Half Yearly Report
February 28, 2018
Rhythm reports reagent development update
February 7, 2018
Quarterly report and Appendix 4C
January 30, 2018
CSIRO and Rhythm Commence Development of Key Reagents
January 24, 2018
CSIRO to assist Rhythm Biosciences develop key reagents
January 8, 2018
Admission to Official List
December 6, 2017